Sarmey, N., Murphy, E., Leyrer, C., Stevens, G., Peereboom, D., & Ahluwalia, M. (2015). ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE. Neuro Oncol.

Sarmey, Nehaw, Erin Murphy, Charles Leyrer, Glen Stevens, David Peereboom, و Manmeet Ahluwalia. "ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE." Neuro Oncol 2015.

Sarmey, Nehaw, et al. "ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE." Neuro Oncol 2015.